-
Sun, Nov 1, 2026 10
-
WP35 Phase 9: three adversarial reviews, corrections A-002–A-007 (placebo, CV folds, robustness variants, item-level analysis, simulation accounting), reruns, revised manuscript (80 pp.), response to reviewers, final audit
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35: leakage check (A-001), Holm table, replication guide, raw-data README, final audit draft, series README rows
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 8: full LaTeX manuscript (73 pp.), bibliography, README
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phases 4–5: modern-panel H2 (rerun with corrected placebo/negative control), simulation runs and analysis
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 4–5 (in progress): H1 associations, H2 Seshat results, identification note, simulation model + factorial runs
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 3: formal framework (5 theorems, 3 conjectures), D/K/P indices with IRT alternative, measurement diagnostics, a-priori power
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 2: harmonized Seshat/D-PLACE/modern panels, coverage + missingness diagnostics, data dictionary, parser tests
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 1: literature review, novelty matrix, Crossref-verified reference list, frozen pre-registration (D-003)
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>
-
WP35 Phase 0: environment audit, source registry, raw acquisition (8 sources, SHA-256), feasibility report
…
Co-Authored-By: Claude Fable 5.1 <noreply@anthropic.com>